Compositional and Functional Analysis of Breast Density in Human Tissue
人体组织乳腺密度的组成和功能分析
基本信息
- 批准号:7615723
- 负责人:
- 金额:$ 22.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectApoptosisAreaBenignBindingBiologicalBiological MarkersBiopsyBreastCellsCollaborationsDataDatabasesDevelopmentDistalDistantEnd PointEnsureEpithelialEpithelial CellsEpithelial-Stromal CommunicationEpitheliumEvaluationExhibitsExtracellular MatrixFibroblastsFutureGeneticGlandHistologicHumanImageIn VitroIncidenceIndividualInsulin-Like Growth Factor ILeadLinkMalignant - descriptorMalignant NeoplasmsMammary Gland ParenchymaMammary glandMammographic DensityMastectomyMetabolicModelingMolecularMolecular ProfilingMorphogenesisMusNormal tissue morphologyParaffinParticipantPathologic ProcessesPathway interactionsPhenotypeRecombinantsResearch PersonnelResourcesReverse Transcriptase Polymerase Chain ReactionRiskSamplingSignal PathwaySignal TransductionSignal Transduction PathwaySiteSomatomedinsSpecimenStagingTestingThea PlantTissuesTranslatingTumorigenicityValidationWomanWound Healingadipocyte differentiationbasebreast densitycDNA Arrayscancer riskdensityhuman tissuein vivoin vivo Modelinsightintercellular communicationmalignant breast neoplasmmigrationmouse modelnovelprogramsreconstructionresearch studytumor progressiontumorigenic
项目摘要
Mammographic breast density is a strong predictor of breast cancer risk. Women with radiodense areas
covering greater than 50% of the tissue area have a 3 to 5 fold increase in risk for breast cancer compared
with women with little or no radiodense area. It is estimated that almost 1/3 of breast cancer incidence is
due to biological variables (both genetic and environmental) that modulate breast density. Given this
strong correlation between breast density and risk for breast cancer, it is surprising that so little is known
about the character or origin of dense breast tissue.
We hypothesize that the molecular interactions between stroma and epithelium represent some of
the very first changes that occur within breast tissue allowing malignant transformation and may therefore
serve as a predictor of breast cancer in its earliest stages. We propose that features of increased stromal
remodeling noted in the extracellular matrix (ECM) and molecular markers in mammographically dense
breasts are indicative of an 'activated' stroma. Activated stroma (AS) is similar to stroma formed during
normal, non-pathological processes such as morphogenesis and wound healing, and can also be found in
pathological states such as desmoplasia. While normal stromal-epithelial interactions actively suppress
preneoplastic phenotypes, activated stroma can become an active participant in cancer progression. We
hypothesize that the mechanistic links between high breast density and increased breast cancer
risk lie in the signal transduction pathways that lead to increased breast density and
concomitantly promote malignant progression in initiated cells in the adjacent epithelium. This
proposal will examine several aspects of the phenotypic, molecular and functional differences of
mammary fibroblasts and epithelial cells isolated from individuals with high or low mammographic density
that have or have not developed breast cancer. Histologic and molecular evaluation of these tissues will
provide novel markers that define increased breast density and increased cancer risk. In Project 2, we will
1) Determine the cellular and histological composition of human breast tissues with high and low
mammographic density. A three-dimensional reconstruction (3D) of the gland, linked to the BioSig
database, will integrate this morphologic data with molecular data. (2) Using cDNA microarrays, we will
compare expression profiles from tissues with high and low mammographic densities (a) to each other
and (b) to matched tissues from individuals that have developed cancer at a distant site. These markers
can be used in Project 3 to evaluate paraffin-preserved benign breast biopsy tissue by immunostains for
association of risk for breast cancer. In Specific Aim 3 In vivo and in vitro recombinant experiments will
provide insights into the cell combinations that generate increased breast density and molecular markers
associated with increased breast cancer risk. (3) Finally we will determine the functional phenotype of
fibroblast cells obtained from human breast tissues with high and low mammographic density. We have
found that fibroblasts from tissue with high mammographic density retain differential expression of
biologically relevant pathways such as the IGF-axis. These fibroblasts have been demonstrated to
facilitate tumor progression when placed in a murine recombinant model. The proposed studies will
determine the molecular basis for fibroblast enhancement of tumorigenic phenotypes.
乳腺摄影乳腺密度是乳腺癌风险的一个强有力的预测因素。有放射性致密区的女性
乳腺癌的风险增加3至5倍,
很少或没有放射密度区的女性。据估计,近1/3的乳腺癌发病率是
这是由于调节乳腺密度的生物学变量(遗传和环境)。鉴于这种
乳腺密度和乳腺癌风险之间存在很强的相关性,令人惊讶的是,
关于致密乳腺组织的特征或起源。
我们假设基质和上皮之间的分子相互作用代表了
乳腺组织内发生的第一个变化允许恶性转化,
作为早期乳腺癌的预测指标。我们认为,基质增加的特征
在乳腺X线摄影致密组织中的细胞外基质(ECM)和分子标记物中观察到重塑,
乳房是“激活的”基质的指示。活化的基质(AS)类似于
正常的非病理过程,如形态发生和伤口愈合,也可以在
病理状态如结缔组织增生。虽然正常的基质-上皮相互作用积极抑制
在肿瘤前表型中,活化的基质可以成为癌症进展的积极参与者。我们
假设高乳腺密度和乳腺癌增加之间的机械联系
风险在于导致乳腺密度增加的信号转导途径,
同时促进邻近上皮中起始细胞的恶性进展。这
该提案将研究表型,分子和功能差异的几个方面,
从具有高或低乳房摄影密度的个体分离的乳腺成纤维细胞和上皮细胞
患或未患乳腺癌的人。这些组织的组织学和分子学评价将
提供了新的标志物,确定乳腺密度增加和癌症风险增加。在项目2中,我们
1)确定高和低浓度乳腺癌患者乳腺组织的细胞和组织学组成,
乳房摄影密度腺体的三维重建(3D),连接到BioSig
数据库,将整合这种形态学数据与分子数据。(2)使用cDNA微阵列,我们将
将来自具有高和低乳腺摄影密度的组织的表达谱相互比较(a)
和(B)来自已在远处发生癌症的个体的匹配组织。这些标记
可用于项目3,通过免疫染色评估石蜡保存的良性乳腺活检组织,
乳腺癌的发病风险。具体目标3体内和体外重组实验将
提供了深入了解细胞组合,产生增加乳腺密度和分子标记
与乳腺癌风险增加有关。(3)最后,我们将确定的功能表型
从具有高和低乳腺摄影密度的人乳腺组织获得的成纤维细胞。我们有
发现来自高乳腺摄影密度组织的成纤维细胞保留了
生物学相关的途径,如IGF轴。这些成纤维细胞已被证明
当置于鼠重组模型中时促进肿瘤进展。拟议的研究将
确定成纤维细胞增强肿瘤发生表型的分子基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thea D Tlsty其他文献
Thea D Tlsty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thea D Tlsty', 18)}}的其他基金
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
与细胞应激和恶性肿瘤相关的塑性状态:预防和治疗致命化生性癌症的见解
- 批准号:
10318925 - 财政年份:2016
- 资助金额:
$ 22.4万 - 项目类别:
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
与细胞应激和恶性肿瘤相关的塑性状态:预防和治疗致命化生性癌症的见解
- 批准号:
8956206 - 财政年份:2016
- 资助金额:
$ 22.4万 - 项目类别:
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
与细胞应激和恶性肿瘤相关的塑性状态:预防和治疗致命化生性癌症的见解
- 批准号:
9207073 - 财政年份:2016
- 资助金额:
$ 22.4万 - 项目类别:
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
与细胞应激和恶性肿瘤相关的塑性状态:预防和治疗致命化生性癌症的见解
- 批准号:
10064604 - 财政年份:2016
- 资助金额:
$ 22.4万 - 项目类别:
Biological Basis of Breast Density and Cancer Risk
乳房密度和癌症风险的生物学基础
- 批准号:
7615729 - 财政年份:2006
- 资助金额:
$ 22.4万 - 项目类别:
Biological Basis of Breast Density and Cancer Risk
乳房密度和癌症风险的生物学基础
- 批准号:
7488340 - 财政年份:2006
- 资助金额:
$ 22.4万 - 项目类别:
The Biological Basis of Breast Density and Cancer Risk
乳房密度和癌症风险的生物学基础
- 批准号:
7028025 - 财政年份:2006
- 资助金额:
$ 22.4万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 22.4万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 22.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 22.4万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 22.4万 - 项目类别:
Discovery Grants Program - Individual